Table 3.
Comparison of ECG parameters in patients with initially successful and failed RFCA (N = 154).
Initially success N = 136 | Failure N = 18 | P value | |
---|---|---|---|
Interpolated VPCs (%) | 23 (16.9%) | 1 (5.6%) | 0.310 |
Retrograde P-wave (%) | 35 (25.7%) | 4 (22.2%) | 1 |
QRS ugly sign (%) | 11 (8.1%) | 2 (11.1%) | 0.651 |
Pseudo delta wave (%) | 22 (16.2%) | 8 (44.4%) | 0.009∗∗ |
QTc interval (ms) | 430.38 ± 26.56 | 435.50 ± 28.25 | 0.978 |
QRS duration in lead II (ms) | 151.51 ± 14.62 | 154.50 ± 22.83 | 0.068 |
R wave amplitude in lead II (mV) | 1.88 ± 0.48 | 2.03 ± 0.40 | 0.290 |
QRS duration in lead III (ms) | 148.33 ± 14.47 | 152.39 ± 18.51 | 0.219 |
R wave amplitude in lead III (mV) | 1.80 ± 0.57 | 2.15 ± 0.74 | 0.209 |
QRS duration in lead aVF (ms) | 149.12 ± 14.54 | 152.33 ± 35.42 | 0.081 |
R wave amplitude in lead aVF (mV) | 1.82 ± 0.52 | 1.97 ± 0.53 | 0.339 |
Q wave amplitude in lead aVR (mV) | 0.92 ± 0.22 | 1.00 ± 0.22 | 0.280 |
Q wave amplitude in lead aVL (mV) | 0.81 ± 0.37 | 0.96 ± 0.41 | 0.333 |
R-wave ratio of leads III/II | 0.98 ± 0.20 | 1.00 ± 0.24 | 0.715 |
Q-wave ratio of leads aVL/aVR | 0.91 ± 0.43 | 0.91 ± 0.51 | 0.980 |
MDI of inferior lead | 0.57 ± 0.08 | 0.58 ± 0.09 | 0.512 |
R wave amplitude in V1 (mV) | 0.23 ± 0.24 | 0.35 ± 0.44 | 0.036∗ |
IDT in lead V2 (ms) | 44.00 ± 18.33 | 57.41 ± 20.67 | 0.005∗∗ |
RS duration in V2 (ms) | 93.67 ± 21.33 | 106.93 ± 18.76 | 0.004∗∗ |
QRS duration in V2 (ms) | 147.82 ± 17.95 | 153.11 ± 16.61 | 0.205 |
R wave amplitude in V2 (mV) | 0.42 ± 0.49 | 0.71 ± 0.58 | 0.056 |
S wave amplitude in V2 (mV) | 1.94 ± 0.91 | 1.61 ± 1.04 | 0.145 |
R/S ratio in lead V2 | 0.21 ± 0.32 | 0.37 ± 0.90 | 0.032∗ |
∗P < 0.05, ∗∗P < 0.01.